Brian L. Hillcoat

1.3k total citations
47 papers, 1.1k citations indexed

About

Brian L. Hillcoat is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Brian L. Hillcoat has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Brian L. Hillcoat's work include Biochemical and Molecular Research (8 papers), Folate and B Vitamins Research (7 papers) and Protein purification and stability (4 papers). Brian L. Hillcoat is often cited by papers focused on Biochemical and Molecular Research (8 papers), Folate and B Vitamins Research (7 papers) and Protein purification and stability (4 papers). Brian L. Hillcoat collaborates with scholars based in Australia, United States and Canada. Brian L. Hillcoat's co-authors include Raymond L. Blakley, Peter F. Nixon, Joseph R. Bertino, John P. Perkins, Ian Roos, Jack Gauldie, J.R. Bertino, James F. Bishop, W. David McFadyen and Ian Olver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Brian L. Hillcoat

46 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian L. Hillcoat Australia 18 564 222 171 165 130 47 1.1k
Jerry L. McCullough United States 26 458 0.8× 177 0.8× 102 0.6× 76 0.5× 74 0.6× 62 1.9k
Atsuko Ogawa Japan 20 332 0.6× 84 0.4× 169 1.0× 58 0.4× 35 0.3× 65 1.3k
Joseph M. Hill United States 16 262 0.5× 151 0.7× 81 0.5× 48 0.3× 41 0.3× 35 863
Naoya Kitamura Japan 22 617 1.1× 217 1.0× 67 0.4× 90 0.5× 70 0.5× 64 1.5k
Adil H. H. Bashir United States 13 583 1.0× 222 1.0× 257 1.5× 296 1.8× 47 0.4× 30 1.5k
A.M.E. Nouri United Kingdom 16 292 0.5× 200 0.9× 170 1.0× 131 0.8× 18 0.1× 62 1.1k
Aftab A. Ansari United States 16 361 0.6× 75 0.3× 88 0.5× 111 0.7× 52 0.4× 45 1.1k
William M. Weaver United States 14 870 1.5× 370 1.7× 29 0.2× 76 0.5× 31 0.2× 15 2.5k
R. P. Agarwal United States 17 941 1.7× 136 0.6× 27 0.2× 50 0.3× 106 0.8× 28 1.3k
Herbert G. Johnson United States 25 370 0.7× 112 0.5× 74 0.4× 50 0.3× 22 0.2× 67 1.6k

Countries citing papers authored by Brian L. Hillcoat

Since Specialization
Citations

This map shows the geographic impact of Brian L. Hillcoat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Hillcoat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Hillcoat more than expected).

Fields of papers citing papers by Brian L. Hillcoat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. Hillcoat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Hillcoat. The network helps show where Brian L. Hillcoat may publish in the future.

Co-authorship network of co-authors of Brian L. Hillcoat

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Hillcoat. A scholar is included among the top collaborators of Brian L. Hillcoat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Hillcoat. Brian L. Hillcoat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webster, Lorraine K., et al.. (2000). A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 45(1). 55–58. 9 indexed citations
2.
Webster, Lorraine K., Glen B. Deacon, Brian L. Hillcoat, et al.. (1992). cis-Bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activity. Journal of Medicinal Chemistry. 35(18). 3349–3353. 32 indexed citations
3.
Reece, Phillip A., et al.. (1990). Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion. Cancer Chemotherapy and Pharmacology. 25(4). 274–278. 3 indexed citations
4.
Olver, Ian, Phillip A. Reece, James F. Bishop, et al.. (1990). A Phase I Study of Doxifluridine as a Five-Day Stepped-Dose Continuous Infusion. American Journal of Clinical Oncology. 13(4). 308–311. 2 indexed citations
5.
Hillcoat, Brian L., Derek Raghavan, JP Matthews, et al.. (1989). A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.. Journal of Clinical Oncology. 7(6). 706–709. 73 indexed citations
6.
Olver, Ian, et al.. (1989). A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy. European Journal of Cancer and Clinical Oncology. 25(10). 1457–1461. 16 indexed citations
7.
Farnworth, Paul G., Brian L. Hillcoat, & Ian Roos. (1989). Metallothionein induction in mouse tissues by cis-Dichlorodiammineplatinum(II) and its hydrolysis products. Chemico-Biological Interactions. 69(4). 319–332. 13 indexed citations
8.
Hillcoat, Brian L.. (1989). Priorities in experimental therapeutics—A surfeit of riches. European Journal of Cancer and Clinical Oncology. 25(9). 1263–1269. 1 indexed citations
9.
Olver, Ian, Ian Roos, Kim S Thomas, & Brian L. Hillcoat. (1989). Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics. Chemico-Biological Interactions. 69(4). 353–357. 7 indexed citations
10.
McFadyen, W. David, L. P. G. Wakelin, Ian Roos, & Brian L. Hillcoat. (1987). The binding of binuclear platinum(II)-terpyridine complexes to DNA. Biochemical Journal. 242(1). 177–183. 35 indexed citations
11.
Bishop, James F., et al.. (1987). Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer.. PubMed. 71(2). 191–3. 4 indexed citations
12.
Hillcoat, Brian L., et al.. (1985). Phase II trial of VP-16-213 in advanced ovarian carcinoma. Gynecologic Oncology. 22(2). 162–166. 24 indexed citations
13.
Hillcoat, Brian L., et al.. (1983). Treatment of advanced malignant hemangiopericytoma with combination adriamycin and dtic: A report of four cases. Journal of Surgical Oncology. 22(3). 167–170. 46 indexed citations
14.
Sutton, Janette, Ian Roos, & Brian L. Hillcoat. (1982). Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.. PubMed. 42(12). 5172–5. 6 indexed citations
15.
Hillcoat, Brian L., et al.. (1971). STABILIZATION OF DIHYDROFOLATE REDUCTASE BY INHIBITORS IN VIVO AND IN VITRO*. Annals of the New York Academy of Sciences. 186(1). 187–205. 5 indexed citations
16.
Perkins, John P., Brian L. Hillcoat, & Joseph R. Bertino. (1967). Dihydrofolate Reductase from a Resistant Subline of the L1210 Lymphoma. Journal of Biological Chemistry. 242(20). 4771–4776. 102 indexed citations
17.
Hillcoat, Brian L., John P. Perkins, & Joseph R. Bertino. (1967). Dihydrofolate Reductase from the L1210 R Murine Lymphoma. Journal of Biological Chemistry. 242(20). 4777–4781. 15 indexed citations
18.
Hillcoat, Brian L. & Raymond L. Blakley. (1964). The reduction of folate by borohydride and by dithionite. Biochemical and Biophysical Research Communications. 15(4). 303–307. 14 indexed citations
19.
Hillcoat, Brian L.. (1962). Calcification of the Meconium within the Bowel of the Newborn. Archives of Disease in Childhood. 37(191). 86–89. 18 indexed citations
20.
Hillcoat, Brian L.. (1960). URINARY AMINO‐ACID EXCRETION IN HEALTH AND DISEASE. Australasian Annals of Medicine. 9(4). 276–282. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerry L. McCullough Breakdown of academic impact, for papers by Atsuko Ogawa Breakdown of academic impact, for papers by Joseph M. Hill Breakdown of academic impact, for papers by Naoya Kitamura Breakdown of academic impact, for papers by Adil H. H. Bashir Breakdown of academic impact, for papers by A.M.E. Nouri Breakdown of academic impact, for papers by Aftab A. Ansari Breakdown of academic impact, for papers by William M. Weaver Breakdown of academic impact, for papers by R. P. Agarwal Breakdown of academic impact, for papers by Herbert G. Johnson
Rankless by CCL
2026